The U.S. Food and Drug Administration (FDA) recently amended the emergency use authorizations (EUAs) of the Pfizer-BioNTech and Moderna COVID-19 Vaccines “to authorize bivalent formulations of the vaccines for use as a single booster dose at least two months following …
Dr. Anthony S. Fauci recently announced that he will be stepping down in December from the positions of Director of the National Institute of Allergy and Infectious Diseases (NIAID), Chief of the NIAID Laboratory of Immunoregulation (where he also serves …
The U.S. Food & Drug Administration (FDA) recently “authorized the emergency use of Novavax COVID-19 Vaccine, Adjuvanted for the prevention of COVID-19 caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in individuals 12 through 17 years of age.” On …
Recent FDA Action & Publication Concerning COVID-19 Read more »
Recently, the U.S. Department of Health and Human Services (HHS), Department of Labor (DoL), and Department of the Treasury jointly issued guidance clarifying “protections for birth control coverage under the Affordable Care Act (ACA, Pub. L. 111-148).” Announcing the guidance, …
Recent HHS, Labor and Treasury Departments Guidance on ACA Birth Control Coverage Read more »
Part of the 7/8/2022 Executive Order 14076 – Protecting Access to Reproductive Healthcare Services – required the U.S. Federal Trade Commission (FTC) to consider actions “to protect consumers’ privacy when seeking information about the provision of reproductive healthcare services.” On …
Recent FTC Commitment on Protecting Consumers’ Health Privacy Read more »
